The expression of LRG1 gene in hepatocellular carcinoma

XI  Zhen-Chang; ZHANG  Jian-Song

PDF(1866 KB)

Journal of Hunan Normal University(Medical Science) ›› 2015, Vol. 12 ›› Issue (2) : 24-27.

The expression of LRG1 gene in hepatocellular carcinoma

Author information +

History +

Abstract

Objective To investigate the expression of leucine-rich-alpha-2-glycoprotein 1(LRG1 ) in hepatocellular carcinoma
(HCC) Cell lines and tissue, and to explore its relationship with HCC progression. Methods qRT-PCR and Western
blot analysis were used to detect LRG1 mRNA and protein expression respectively in 6 hepatocellular carcinoma cell lines, 30
paired HCC and adjacent normal liver tissues. Results The levels of LRG1mRNA and protein expression hepatocellular carcinoma
cell lines mRNA, protein levels LRG1 significantly higher than normal liver cells L02, the of invasion and metastasis
of HCC cell lines positive correlation with LRG1 expression levels. The levels of LRG1 mRNA and protein expression in HCC
were significantly higher than those in adjacent liver tissues. Conclusion LRG1 overexpression has a significant correlation
with the progression of HCC, and it would designing new targeted drugs.

Key words

hepatocellular carcinoma / leucine-rich repeat protein 1 / invasion and metastasis;

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

XI Zhen-Chang, ZHANG Jian-Song. The expression of LRG1 gene in hepatocellular carcinoma[J]. Journal of Hunan Normal University(Medical Science). 2015, 12(2): 24-27

References

［ 1］郑核, 钟德玝, 罗赤黄, 等. Plk1在肝癌组织中表达及意义［J］. 湖南

师范大学学报(医学版), 2012, (2): 15-1 .

［ 2］ Forner, A, Llovet JM, BruixJ. Hepatocellular carcinoma［J］. Lancet,

2012, ( 22): 12 5-1255.

［］ Hanahan, D, Weinberg RA, Hallmarks of Cancer: The Next Generation

［J］. Cell, 2011, 1 (5): - .

［］ Wang, X, et al., LRG1 promotes angiogenesis by modulating endothelial

TGF-β signalling. Nature, 201 . ( 5 ): 0 - 11.

［ 5］ Yu DC, Chen J, Ding YT. Hypoxic and Highly Angiogenic Non-Tumor

Tissues Surrounding Hepatocellular Carcinoma: The‘ Niche’ of Endothelial

Progenitor Cells［J］. Int J Mol Sci, 2010. 11( ): 2 01-2 0 .

［］ Zhu AX, Duda DG, Sahaui DV, et al., HCC and angiogenesis: possible

targets and future directions［J］. Nat Rev Clin Oncol, 2011, (5):

2 2- 01.

［］ Kobe, B, Kajava AV. The leucine-rich repeat as a protein recognition

motif［J］. 2001, 11( ): 25- 2.

［］ Saito K, Tanaka T, Kanda H, et al. Gene Expression Profiling of Mucosal

Addressin Cell Adhesion Molecule-1+ High Endothelial Venule

Cells (HEV) and Identification of a Leucine-Rich HEV Glycoprotein as

a HEV Marker［J］. J Immunol, 2002, 1 ( ): 1050-105 .

［］ Li X, Miyajiwa, M, Jiang C, et al. Expression of TGF-βs and TGF-β

type II receptor in cerebrospinal fluid of patients with idiopathic normal

pressure hydrocephalus［J］. Neurosci Lett, 200 . 1 (2): 1 1-1 .

［10］ Liu YS, Luo XY, Li QR, et al. Shotgun and targeted proteomics reveal

that pre-surgery serum levels of LRG1, SAA, and C BP may refine

prognosis of resected squamous cell lung cancer［J］. J Mol Cell Biol,

2012, (5): - .

［11］ Ladd, JJ, Busald T, John Son MM, et al, Increased Plasma Levels of the

APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a

Diagnosis of Colorectal Cancer in Women［J］. Cancer Prev Res, 2012,

5( ): 55- .

［12］ Andersen JD, Boylan KL, Jemmerson R, et al. Leucine-rich alpha-

2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer

patients［J］. J Ovarian Res, 2010, : 21.

［1 ］ Kakisaka T, Kondo T, Okano T, et al. Plasma proteomics of pancreatic

cancer patients by multi-dimensional liquid chromatography and twodimensional

difference gel electrophoresis (2D-DIGE): up-regulation

of leucine-rich alpha-2-glycoprotein in pancreatic cancer［J］. J Chromatogr

B Analyt Technol Biomed Life Sci, 200 . 52(1-2): 25 - .

［1 ］ Carmeliet P, Jain RK. Molecular mechanisms and clinical applications

of angiogenesis［J］. Nature, 2011. ( ): 2 - 0 .

［15］ Chaudhary A, Hilton MB, Seawan S, et al. TEM /ANTXR1 blockade

inhibits pathological angiogenesis and potentiates tumoricidal responses

against multiple cancer types［J］. Cancer Cell, 2012, 21(2): 212-2 .